🏛️ Verified NIH Record • Updated 2026-02-25
Trial of Ixazomib for Kaposi Sarcoma (NCT04305691)
A Phase 2 Trial of Ixazomib for Kaposi Sarcoma
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: AIDS Malignancy Consortium
🩺 Plain-English Summary (8th-Grade Level)
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Who can join: Review the eligibility criteria below.
Location: UC San Diego — San Diego, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- UC San Diego — San Diego, California
- Zuckerberg San Francisco General Hospital — San Francisco, California
- University of Miami Miller School of Medicine — Miami, Florida
- University of Illinois Cancer Center — Chicago, Illinois
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
- Washington University — St Louis, Missouri
- Mount Sinai Hospital — New York, New York
- Abramson Cancer Center at Pennsylvania Hospital — Philadelphia, Pennsylvania
- Thomas Street Clinic — Houston, Texas
- Thomas Street Clinic — Houston, Texas
- Virginia Mason Medical Center — Seattle, Washington
📞 Contact the Study Coordinator
Phone: (858) 822-6100
Email: egreid@ucsd.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Kaposi Sarcoma
- Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma — Bethesda, Maryland
- Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis — Bethesda, Maryland
- A Study of Propranolol to Treat Kaposi Sarcoma — Buenos Aires,
- Propranolol for the Treatment of Kaposi Sarcoma in Adults — St Louis, Missouri
- Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma — Bethesda, Maryland
- Natural History Study of Kaposi Sarcoma — Bethesda, Maryland
Explore by condition: All Kaposi Sarcoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.